newsfilter
← Latest News
Business Wire·

Edwards Lifesciences Reports Third Quarter Results

EW

Edwards Lifesciences (NYSE:EW) today reported financial results for the quarter ended September 30, 2025. Recent Highlights Q3 sales grew 14.7% to $1.55 billion, or 12.6% adjusted1, with strength across all product